US 10,376,557 B2
Peptide fragments for inducing synthesis of extracellular matrix proteins
Scott M. Harris, Seattle, WA (US); Timothy J. Falla, Woodinville, WA (US); and Lijuan Zhang, Kenmore, WA (US)
Assigned to Helix Biomedix Inc., Bothell, WA (US)
Filed by HELIX BIOMEDIX, INC., Bothell, WA (US)
Filed on Aug. 17, 2016, as Appl. No. 15/239,708.
Application 13/339,606 is a division of application No. 11/811,876, filed on Jun. 12, 2007, granted, now 8,110,658, issued on Feb. 7, 2012.
Application 15/239,708 is a continuation of application No. 14/531,081, filed on Nov. 3, 2014, granted, now 9,447,143.
Application 14/531,081 is a continuation of application No. 13/961,782, filed on Aug. 7, 2013, granted, now 8,962,798, issued on Feb. 24, 2015.
Application 13/961,782 is a continuation of application No. 13/339,606, filed on Dec. 29, 2011, granted, now 8,658,764, issued on Feb. 25, 2014.
Claims priority of provisional application 60/813,284, filed on Jun. 13, 2006.
Prior Publication US 2017/0157196 A1, Jun. 8, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/07 (2006.01); C07K 5/10 (2006.01); C07K 5/103 (2006.01); C07K 5/117 (2006.01); A61K 8/64 (2006.01); A61Q 19/00 (2006.01); C07K 14/78 (2006.01); A61Q 19/08 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 38/00 (2006.01)
CPC A61K 38/07 (2013.01) [A61K 8/64 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); C07K 5/1002 (2013.01); C07K 5/1008 (2013.01); C07K 5/1024 (2013.01); C07K 14/78 (2013.01); A61K 38/00 (2013.01); A61K 2121/00 (2013.01); A61K 2300/00 (2013.01)] 19 Claims
 
1. A skincare composition comprising a tetrapeptide consisting of SEQ ID NO:1 or SEQ ID NO:14, and a dermatologically acceptable carrier.